scholarly journals Recurrent Mitral Valve Endocarditis Caused byStreptococcus pneumoniaein a Splenectomized Host

2013 ◽  
Vol 2013 ◽  
pp. 1-4
Author(s):  
Shikha Shrestha ◽  
JayaKrishna Chintanaboina ◽  
Samir Pancholy

A 72-year-old male with a remote history of splenectomy and two previous episodes of pneumococcal endocarditis of mitral valve presented with high-grade fever and confusion for 3 days. Nine months priorly, patient underwent mitral valve repair when he had the first episode of pneumococcal mitral valve endocarditis. He received pneumococcal vaccination two years ago. On examination during this admission, he was found to be febrile (104.3 F) and confused and had a grade 2/6 systolic murmur at the apex without any radiation. Laboratory data was significant for a white blood cell count of 22,000/mm3(normal: 4000–11000/mm3). Blood cultures (4/4 bottles) grew penicillin-sensitiveStreptococcus pneumoniae. Transesophageal echocardiogram revealed small vegetation on the posterior mitral leaflet without any evidence of abscess and severe mitral regurgitation. Patient clinically responded to intravenous ceftriaxone. However, due to recurrent pneumococcal mitral valve endocarditis and severe mitral regurgitation, the patient underwent mitral valve replacement. Patient had an uneventful recovery and was discharged home. Pneumococcal endocarditis itself is being uncommon in this current, penicillin, era; our case highlights the recurrent nature of pneumococcal endocarditis in a splenectomized host and the importance of pursuing aggressive treatment options in this clinical scenario.

2020 ◽  
Vol 8 ◽  
pp. 2050313X2093695
Author(s):  
Abigayle Sullivan ◽  
Pragya Shrestha ◽  
Sijan Basnet ◽  
Ronald Herb ◽  
Emily Zagorski

We report a case of an elderly Caucasian male with past medical history of dextrocardia with situs inversus totalis, polymyalgia rheumatica, history of cryptogenic stroke, and severe mitral regurgitation with mitral valve prolapse, who presented with acute heart failure symptoms, including severe dyspnea on exertion and worsening lower extremity edema in the setting of immunosuppression with steroids for a year-old diagnosis of polymyalgia rheumatica. One month prior to this presentation, the patient suffered a transient ischemic attack and during the workup, his transthoracic echocardiography showed myxomatous degeneration of posterior mitral leaflet, partially flail, with severe mitral regurgitation, which required mitral valve replacement. Genome sequencing of mitral valve anterior leaflet pathology detected Tropheryma whipplei as a causal agent of culture-negative endocarditis. The patient was treated with 6 weeks of ceftriaxone and ampicillin–sulbactam and further continued trimethoprim–sulfamethoxazole for 1 year. He continued antibiotic treatment with resolution of shortness of breath along with arthralgia.


2015 ◽  
Vol 18 (1) ◽  
pp. 033
Author(s):  
Serhat Caliskan ◽  
Feyzullah Besli ◽  
Saim Sag ◽  
Fatih Gungoren ◽  
Ibrahim Baran

During pregnancy, infective endocarditis (IE) is quite rare but has a high mortality rate in terms of the mother and the fetus. In this article, a 24-year-old patient with a history of mitral valve prolapse (MVP) who was hospitalized due to IE and treated successfully is presented. On echocardiography, severe mitral valve prolapse, severe mitral regurgitation, and vegetation on the posterior leaflet of mitral valve were observed. Streptococcus mitis was subsequently isolated from four sets of blood cultures. The patient was diagnosed with IE. After 6 weeks of antibiotic therapy, the patient was cured completely without surgical treatment. At 40-weeks of pregnancy, the patient gave birth via a normal vaginal delivery. There were no problems with the 3,800-gram baby born. In current guidelines, there is very limited advice on treatment options for patients who develop IE during pregnancy. Therefore, evaluation of patient-based treatment options would be appropriate. In addition, IE prophylaxis for MVP is not recommended in current guidelines. However, in MVP patients with mitral regurgitation, prior to procedures associated with a high risk of infective endocarditis, IE prophylaxis may be rational.


2020 ◽  
Vol 21 (Supplement_1) ◽  
Author(s):  
G Ramirez-Escudero Ugalde ◽  
M Codina Prat ◽  
R Candina Urizar ◽  
N Garcia Ibarrondo ◽  
A Manzanal Rey ◽  
...  

Abstract Nonbacterial thrombotic endocarditis is frequently diagnosed in postmortem autopsies. However, in some patients with systemic diseases it is diagnosed in the context of multiple embolic events, so a high degree of clinical suspicion must be maintained to offer the best treatment to these patients. We report a case of a 59-year-old woman with diagnosis of stage IV lung adenocarcinoma in the context of first episode of cardiac tamponade requiring urgent pericardiocentesis. She was admitted to the emergency department for an acute ischemic stroke, so antiplatelet therapy was started and chemotherapy discontinued. After few weeks, she required new admission due to progression of the oncological disease and bilateral pulmonary thromboembolism secondary to deep vein thrombosis of the lower extremities. Given the progression of the disease, it was decided not to return to chemotherapy and to start anticoagulant therapy with low molecular weight heparin. A transthoracic echocardiogram (TTE) was requested, which highlighted a thickened mitral valve with severe mitral regurgitation, not present in the TTE performed one year before. She was asymptomatic, without fever, with repeatedly negative blood cultures and absence of infectious markers. A new TTE was repeated 4 weeks later, beeing under antiplatelet and anticoagulant treatment, observing a greater thickening of both mitral leaflets with nodular image on the anterior mitral leaflet, persisting a severe mitral regurgitation. Given the low probability of infective endocarditis, these findings were attributed to a nonbacterial thrombotic endocarditis in the context of a progressive malignant disease. Nonbacterial thrombotic endocarditis is characterized by the presence of sterile vegetations formed by the accumulation of platelets and fibrin. It is associated with neoplastic processes (specially with mucinous adenocarcinomas) as well as with autoimmune, rheumatologic and infectious processes. These vegetations tend to produce multiple systemic embolizations, which usually manifests as the first symptom. Patients do not usually present murmurs in the physical examination, nor fever, and blood cultures are negative. It is necessary to complete the study with a TTE, where the left valves tend to be affected more frequently (mitral valve in 2/3 of the cases). In case of doubt, the study should be completed with a TEE, although neither of these techniques differentiates infectious vegetations from thrombotic ones. Treatment consists of treating the underlying cause and starting anticoagulation with heparin to prevent new embolisms. In some isolated cases the surgical treatment of this entity has been proposed. Conclusion presence of nonbacterial thrombotic endocarditis should be suspected in all patients with multiple embolisms and concomitant systemic disease. Study must be completed with a TTE/TEE and anticoagulant treatment should be started. Abstract P691 Figure. A: Mitral valve 1 year before. B: now


2011 ◽  
Vol 6 (1) ◽  
pp. 62
Author(s):  
Raquel del Valle-Fernández ◽  
Carlos E Ruiz ◽  
◽  

Percutaneous treatment of severe mitral regurgitation is a very interesting therapeutic option for those patients considered not to be suitable candidates for surgery. Different technologies have already demonstrated proof-of-concept, and one of these devices (the Mitraclip device) has already obtained the Conformité Europeéne mark. However, demonstrating safety and efficacy for most of these technologies is being harder than anticipated. Recently, research and development has become more compromised due to the financial crisis. This paper reviews the venues that are currently under evaluation.


2012 ◽  
Vol 93 (6) ◽  
pp. e165
Author(s):  
Mohammad Q. Najib ◽  
Hari P. Chaliki ◽  
Satya S. Vittala ◽  
Amol Raizada ◽  
Roger L. Click

Sign in / Sign up

Export Citation Format

Share Document